Affymax Follow Verify

Affymax, Inc. is a biopharmaceutical company previously committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. Our vision was to become a leader in the nephrology and specialty care space by delivering innovative therapeutic offerings to patients and healthcare providers before a nationwide voluntary recall of OMONTYS® (peginesatide) Injection in February 2013. In March 2013 Affymax commenced a review of strategic alternatives. 

http://www.affymax.com/
Type	Public / Private

Top 5 Recent Tweets

Date	Author	Comment
August 29, 2020	TickerReport	Affymax $AFFY Stock Passes Above 200-Day Moving Average of $0.03 https://t.co/6A00XxpENk
August 29, 2020	dailypoliticaln	Affymax $AFFY Stock Passes Above 200 Day Moving Average of $0.03 https://t.co/zVVI0QXjPy
August 24, 2020	Jasik	$AFFY 0.08 (+71.67%) $89,335 $/v with 121 trades today. https://t.co/eUw718hHal https://t.co/xtSF9hgtRD

Top 5 Lifetime News Headlines

Top Authors

• Napaporn Panomrit
• Ramconstructionshop
• Connie
• View all authors

Verification history

• 389 days ago


• View all verifications